Website
N/ATelephone
N/A
Address
1 Macquarie Place Sydney, New South Wales (NSW) 2000
Description
HealthCo Healthcare & Wellness REIT operates as a real estate investment trust. It invests in various portfolios including hospitals, aged care, childcare, government, life sciences & research and primary care & wellness property assets, as well as other healthcare and wellness property adjacencies. The company is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.27 - 1.8
Trade Value (12mth)
AU$458,104.00
1 week
-4.2%
1 month
-2.14%
YTD
-18.83%
1 year
-15.64%
All time high
2.35507
EPS 3 yr Growth
N/A
EBITDA Margin
106.90%
Operating Cashflow
$11m
Free Cash Flow Return
1.00%
ROIC
1.70%
Interest Coverage
4.10
Quick Ratio
0.00
Shares on Issue (Fully Dilluted)
376m
HALO Sector
Real Estate
Next Company Report Date
08-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
3.10
Date | Announcements |
---|---|
31 March 23 |
Successful Completion of Placement & Inst. Entitlement Offer
×
Successful Completion of Placement & Inst. Entitlement Offer |
31 March 22 |
Becoming a substantial from MQG
×
Becoming a substantial from MQG |
31 August 23 |
Proposed issue of securities - HCW
×
Proposed issue of securities - HCW |
31 August 22 |
Appendix 3Y - Joseph Carrozzi
×
Appendix 3Y - Joseph Carrozzi |
30 September 22 |
Annual Report 2022
×
Annual Report 2022 |
30 March 23 |
Healthscope Portfolio Acquisition and Equity Raising
×
Healthscope Portfolio Acquisition and Equity Raising |
30 March 23 |
Transformational Acquisition and Equity Raising Presentation
×
Transformational Acquisition and Equity Raising Presentation |
30 March 23 |
Cleansing Notice
×
Cleansing Notice |
30 March 23 |
Proposed issue of securities - HCW
×
Proposed issue of securities - HCW |
30 March 23 |
Dividend/Distribution - HCW
×
Dividend/Distribution - HCW |
30 June 22 |
Change in substantial holding from MQG
×
Change in substantial holding from MQG |
30 August 23 |
Application for quotation of securities - HCW
×
Application for quotation of securities - HCW |
29 November 23 |
Application for quotation of securities - HCW
×
Application for quotation of securities - HCW |
29 March 23 |
Pause in Trading
×
Pause in Trading |
29 March 23 |
Trading Halt
×
Trading Halt |
28 August 23 |
Fund Payment Notice
×
Fund Payment Notice |
28 April 23 |
Western Sydney Asset Tour Presentation
×
Western Sydney Asset Tour Presentation |
28 April 23 |
Application for quotation of securities - HCW
×
Application for quotation of securities - HCW |
27 September 23 |
Annual Report 2023
×
Annual Report 2023 |
27 November 23 |
Fund Payment Notice
×
Fund Payment Notice |
26 April 23 |
Successful Completion of Underwritten Retail Offer
×
Successful Completion of Underwritten Retail Offer |
26 April 23 |
Appendix 3Y - David Di Pilla
×
Appendix 3Y - David Di Pilla |
26 April 23 |
Appendix 3Y - Chris Roberts
×
Appendix 3Y - Chris Roberts |
25 September 23 |
First Close on $1.3b Healthcare and Life Sciences Fund
×
First Close on $1.3b Healthcare and Life Sciences Fund |
25 November 22 |
Application for quotation of securities - HCW
×
Application for quotation of securities - HCW |
25 January 23 |
Advance Notice - 2023 Half Year Financial Results
×
Advance Notice - 2023 Half Year Financial Results |
25 January 23 |
Becoming a substantial holder from PPT
×
Becoming a substantial holder from PPT |
24 July 23 |
Chair's Address - EGM 2023
×
Chair's Address - EGM 2023 |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.